Literature DB >> 8246917

Agonist-induced down-regulation and antagonist-induced up-regulation of m2- and m3-muscarinic acetylcholine receptor mRNA and protein in cultured cerebellar granule cells.

F Fukamauchi1, P A Saunders, C Hough, D M Chuang.   

Abstract

Cerebellar granule cells express m2- and m3-muscarinic acetylcholine receptors (mAChRs) and their corresponding mRNA with m3-mAChR being the predominant receptor subtype. After stimulation with the mAChR agonist, carbachol, m2- and m3-mAChR mRNA levels were decreased in a time- and concentration-dependent manner with the maximal down-regulation at 2 and 8 hr, respectively. Immunoprecipitation studies revealed that amounts of m2- and m3-mAChR protein also decreased at 8 and 24 hr, respectively. The carbachol-induced down-regulation of m3-mAChR mRNA was associated with a decrease in the transcription rate, but a substantial enhancement of the mRNA stability. Upon removal of carbachol after treatment for 8 hr, the levels of m3-mAChR mRNA and mAChR binding sites returned to their original values with a t1/2 of approximately 80 min and 6 hr, respectively. The carbachol-elicited loss of m2- and m3-mAChR mRNA was blocked by their corresponding receptor subtype-specific antagonists, AF-DX 116 (m2-selective) and 4-diphenylacetoxy-N-methylpiperidine methiodide (4-DAMP) (m3-selective), and was concurrent with an increase in c-fos mRNA levels. Exposure of granule cells to the nonselective mAChR antagonist, atropine, caused a time- and concentration-dependent increase in the level of both m2- and m3-mAChR mRNA and mAChR binding sites. At 24 hr, immunoprecipitable m3-mAChR protein was predominantly increased. The atropine-induced up-regulation of m3-mAChR mRNA was concurrent with a marked enhancement of the mRNA stability and its transcription rate. The elevated levels of m3-mAChR mRNA and binding sites declined to their untreated values after the removal of atropine. Treatment with AF-DX 116 and 4-DAMP also produced an increase in the level of m2- and m3-mAChR mRNA and their corresponding immunoprecipitable receptor protein. These results demonstrate that the mAChR agonist and antagonist induce a down- and up-regulation of mAChR expression, respectively, through receptor-mediated mechanisms in cerebellar granule cells. Moreover, at least for m3-mAChR mRNA, the agonist- and antagonist-induced effects are reversible and associated with corresponding changes in the transcription rate of this receptor mRNA species.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8246917

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  12 in total

1.  SK & F 96365 inhibits carbachol-induced phosphoinositide turnover in human neuroblastoma SH-SY5Y and rat cerebellar granule cells.

Authors:  W W Lin; C W Wang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-06       Impact factor: 3.000

2.  Muscarinic receptor subtype-3 gene ablation and scopolamine butylbromide treatment attenuate small intestinal neoplasia in Apcmin/+ mice.

Authors:  Jean-Pierre Raufman; Jasleen Shant; Guofeng Xie; Kunrong Cheng; Xue-Min Gao; Brian Shiu; Nirish Shah; Cinthia B Drachenberg; Jonathon Heath; Jürgen Wess; Sandeep Khurana
Journal:  Carcinogenesis       Date:  2011-06-24       Impact factor: 4.944

3.  Involvement of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and p53 in neuronal apoptosis: evidence that GAPDH is upregulated by p53.

Authors:  R W Chen; P A Saunders; H Wei; Z Li; P Seth; D M Chuang
Journal:  J Neurosci       Date:  1999-11-01       Impact factor: 6.167

4.  Axotomy-induced loss of m2 muscarinic receptor mRNA in the rat facial motor nucleus precedes a decrease in concentration of muscarinic receptors.

Authors:  D B Hoover; R H Baisden; J V Lewis
Journal:  Histochem J       Date:  1996-11

5.  Agonist-induced down-regulation of the m4 muscarinic acetylcholine receptor occurs without changes in receptor mRNA steady-state levels.

Authors:  W Lenz; C Petrusch; K H Jakobs; C J van Koppen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-11       Impact factor: 3.000

6.  Long-term carbachol treatment-induced down-regulation of muscarinic M2-receptors but not m2 receptor mRNA in a human lung cell line.

Authors:  E B Haddad; J Rousell; J C Mak; P J Barnes
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

7.  Muscarinic receptor subtype mRNA expression in the human prostate: association with age, pathological diagnosis, prostate size, or potentially interfering medications?

Authors:  Lambertus P W Witte; Christine A Teitsma; Jean J M C H de la Rosette; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-11-06       Impact factor: 3.000

8.  Effect of acetylcholine on pain-related electric activities in hippocampal CA1 area of normal and morphinistic rats.

Authors:  Yu Xiao; Xiao-Fang Yang; Man-Ying Xu
Journal:  Neurosci Bull       Date:  2007-11       Impact factor: 5.203

9.  Cardiovascular safety and overall tolerability of solifenacin in routine clinical use: a 12-week, open-label, post-marketing surveillance study.

Authors:  Martin C Michel; Ulrich Wetterauer; Monika Vogel; Jean J M C H de la Rosette
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

10.  Muscarinic receptors prevent oxidative stress-mediated apoptosis induced by domoic acid in mouse cerebellar granule cells.

Authors:  Gennaro Giordano; Li Li; Collin C White; Fred M Farin; Hui W Wilkerson; Terrance J Kavanagh; L G Costa
Journal:  J Neurochem       Date:  2009-02-07       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.